Treating pigmented lesions like sunspots, age spots, and freckles has long been one of the more nuanced areas of cosmetic dermatology. The challenge is that pigmented spots vary in depth, density, and concentration, even when they appear similar on the surface. Reepot, a laser device developed by Classys and its subsidiary Ilooda in South Korea, addresses that challenge in a way that sets it apart from conventional pigmentation lasers.

What Is Reepot?

Reepot is the world’s first pigmentation-targeted laser with integrated super cooling technology. It is FDA-cleared and approved by Korea’s Ministry of Food and Drug Safety, and uses a 532nm Nd:YAG laser wavelength, which is highly absorbed by melanin, making it well suited for targeting superficial and dermal pigmented lesions.

The AutoDerm AI Guidance System

The most distinctive feature of Reepot is its AutoDerm system. An integrated medical camera collects real-time data on each lesion being treated, then automatically adjusts the laser energy based on the depth and concentration of pigment within that individual spot. Areas with denser pigment receive higher energy; areas with more superficial pigment receive lower energy, all without manual adjustment between shots.

For patients with multiple spots of varying depth across the same area, this intelligent calibration offers a meaningful advantage over fixed-parameter devices that apply the same energy setting to every target regardless of individual lesion characteristics.

Built-In Cooling for Patient Comfort

Reepot incorporates Classys’s CPTL contact cooling system, using a sapphire-tipped handpiece that maintains a constant cooling temperature throughout the procedure. This continuous cryocooling protects the skin surface while allowing high energy to reach the pigment below, making the treatment tolerable for most patients without topical anesthetic.

A Notable Device in Korean Aesthetic Technology

Following the 2024 merger of Classys and Ilooda, Reepot now sits within a portfolio that includes the Ultraformer MPT for HIFU lifting and Everesse for monopolar RF tightening, reflecting the broader trend in Korean aesthetic medicine toward comprehensive, multi-modality treatment platforms.

References: